Bloating and Constipation: The Gas Nobody Measured

She was thirty-three and carried a folder: three stool reports ordered online over fourteen months, each contradicting the last, and four rounds of antimicrobials aimed at whatever organism that quarter’s report had named. Nobody had ever measured her breath. When we did, her fasting methane was 19 ppm, and the symptom she had described as bloating for a decade turned out to be constipation.

Bloating and constipation are what people say when the gut hurts in a way nobody takes seriously. The video Your Gut Bacteria Breathe Out Through Your Mouth, from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, makes the case for measuring. What follows is the practical side for anyone in chronic pain whose abdomen has been written off as stress: what the breath shows, how often it misleads, and what to ask before another prescription.

Why the word you use for the symptom matters

Bloating sends a workup in one direction. Straining sends it in another. The plan tends to follow the word on the intake form rather than the physiology underneath it, so it is worth asking whether the word you have used for years is the word a physician would use.

The recognized symptom set for bacterial overgrowth in the small bowel is bloating, diarrhea and abdominal pain or discomfort, with fatty stools in more severe cases. Routine labs can carry a clue too: an elevated folate paired with a low vitamin B12 is unusual enough to flag on blood work you have already had drawn. In a pain practice, abdominal discomfort that has been folded into a diagnosis of widespread pain deserves that second look. Normal results are exactly what some pain conditions produce.

What a breath test actually reads

Your own cells make no hydrogen. Every molecule of it in your breath came from microbes fermenting something, crossed the gut wall into the blood and left through the lungs. That makes a breath test a readout of what the gut community is doing today, not a roster of who lives there.

The North American Consensus sets the rules. A hydrogen rise of at least 20 ppm from baseline within 90 minutes counts as positive for overgrowth. A methane level of at least 10 ppm counts as positive. Hydrogen, methane and carbon dioxide have to be measured together, because methane-producing organisms use up four hydrogen molecules for each methane molecule they build. A heavy methane producer can show a flat hydrogen curve, and a laboratory reading hydrogen alone will call that patient normal.

Preparation is specified as well: no antibiotics for four weeks beforehand and a fast of 8 to 12 hours. Contrary to common instructions, proton pump inhibitors for acid reflux do not need to be stopped first. Long-term acid suppression raises other questions for pain patients.

How accurate the breath test really is

Not very, and you should hear that before trusting any result. Pooled across case-control studies, 35.5% of people with irritable bowel syndrome test positive, and so do 29.7% of healthy controls. The sugar used distorts it further: compared with glucose, lactulose inflates positivity 3.6-fold in patients and 7.6-fold in controls.

Anatomy explains much of the noise. When positive glucose tests were repeated while a radioactive tracer followed the sugar, 48% were false positives, with the colon fermenting glucose that had arrived early. After previous upper gastrointestinal surgery the false-positive rate reached 65%, and transit to the colon averaged 18 minutes in the false positives against 79 minutes in genuine overgrowth. That study carries limits of its own, including a positivity cutoff no current protocol uses.

The order of tests matters too. Among patients with irritable bowel syndrome and a positive lactulose test, positive fructose tests dropped from 62% to 3% after one week of antibiotics. Nearly every fructose intolerance in that group was bacteria fermenting sugar too early, which is why overgrowth should be ruled out before any lactose or fructose test.

Methane and a slow bowel

This is where the gas earns its place. Breath methane is associated with constipation at an odds ratio of 3.51, and all eight additional papers that looked at transit linked methane with delay. Methane-predominant overgrowth carries five times the likelihood of constipation seen with hydrogen-predominant overgrowth.

A single fasting methane of 10 ppm or more matches the full two-hour protocol at 86.4% sensitivity and 100% specificity. It correlates with stool Methanobrevibacter smithii load, holds stable for 14 weeks without treatment and falls within two days of antibiotics. It also tracks severity, though modestly: constipation scores of 5.65 in methane-positive people against 4.32 in methane-negative people, a real but small gap.

Does clearing the gas change the symptom? In one randomized trial in constipation-predominant irritable bowel syndrome, neomycin plus rifaximin produced a severity score of 28.6 against 61.2 on neomycin alone. Inside the combination arm, patients whose methane fell below 3 ppm scored 30.5, while those with persistent methane scored 67.2. Read it with its fine print: 31 people in the main analysis, no true placebo arm, an entry bar far below today’s 10 ppm, a post-hoc split of 15 patients and four weeks of follow-up. It is the best mechanistic evidence available, and it is thin. Clearing the weeds is rarely the whole problem.

The flat test, and the dull tests that still matter

Some patients produce a flat line: low, fixed hydrogen and no methane. Hydrogen sulfide can now be measured in breath, and in diarrhea-predominant disease higher breath sulfide goes with more sulfide-producing bacteria such as Fusobacterium and Desulfovibrio. Those pathway links were inferred from a database rather than measured, and no consensus body has set a sulfide threshold, so any laboratory cutoff is the laboratory’s own.

For a pain patient with abdominal symptoms, inflammation has to be excluded early. In adults with irritable bowel symptoms, a C-reactive protein of 0.5 or less or a fecal calprotectin of 40 µg/g or less leaves a probability of inflammatory bowel disease of 1% or lower. That is a strong rule-out. It is not a diagnosis, and calprotectin cannot detect bacterial overgrowth. Pain-sensing nerves and gut inflammation influence each other.

What to do before another round of antibiotics

Her four courses were aimed at four names from reports that commercial laboratories cannot agree on. A stool census cannot tell you what the community is doing; a gas can. Notice which test has a product attached. The kit arrives with colored bars and a reorder button, while a breath test that ends the testing sells nothing further.

The society guidance in this field is candid that the definition of overgrowth lacks precision and that treatment after a positive test is mostly empiric, with real risks from long-term broad-spectrum antibiotics. That is the case against testing, made by the people who run the tests. My answer is that a rough reading of the right thing beats an exact reading of the wrong thing, and the alternative on offer is a guess.

So bring questions, not demands. Ask which gases the laboratory measures. Ask whether overgrowth was ruled out before any fructose or lactose test. Ask whether a double peak was used to call you positive, since the consensus no longer accepts it. Note whether the bloating or the straining came first. Do not start, stop or repeat an antibiotic on your own; work it through with your physician. Your sugar cravings run on gut signaling too.

Every figure above, including the sensitivity arithmetic behind the breath test and the full weakness of the methane trials, is in the Angry Gut Deep Dive on breath and biomarker testing. For the patients who do everything right and still do not improve, the next suspect may be the building itself.

Frequently asked questions

Can SIBO cause bloating and constipation at the same time?

Yes, and methane is the usual link. Methane-predominant overgrowth carries five times the likelihood of constipation seen with hydrogen-predominant overgrowth, and breath methane is tied to slower transit across the studies that measured it. One patient described hers as bloating for a decade before a fasting methane of 19 ppm showed constipation. Only a test that measures methane can see it. Gut bacteria shape far more than digestion.

Do I have to stop my acid reflux medication before a breath test?

Under the North American Consensus, proton pump inhibitors do not need to be stopped before breath testing, which contradicts instructions many patients still receive. Antibiotics should be avoided for four weeks beforehand, with an 8 to 12 hour fast and no smoking on the day. The consensus could not agree on probiotics. Any change to your medications belongs with your physician. Gut bacteria leave measurable traces in the blood as well.

Why did my breath test come back flat?

A flat result, with low fixed hydrogen and no methane, does not always mean a quiet gut. The consensus flags that pattern as a possible hydrogen sulfide producer that standard instruments cannot detect. Sulfide is now measurable in breath, and higher levels track with sulfide-producing bacteria in diarrhea-predominant disease, but no consensus body has set a cutoff. Ask exactly which gases your laboratory measured. The microbiome is being studied as a diagnostic clue in pelvic pain too.

Can a fructose breath test give a false result?

Yes, if bacterial overgrowth was not ruled out first. In patients with irritable bowel syndrome who also tested positive on lactulose, positive fructose tests fell from 62% to 3% after a week of antibiotics. Those results reflected bacteria fermenting sugar in the small bowel, not a true intolerance. Before cutting fruit out of your diet for years, ask which test was done first. Sugar substitutes carry their own gut effects.

Is a mail-order stool microbiome test worth it for chronic pain?

Rarely as a guide to treatment. When one identical sample went to six commercial services, diversity verdicts ranged from excellent to unfavorable, and no company disclosed the population it compared against. A species list shows who is present, not what they are doing. For abdominal symptoms, a breath test with all three gases and a calprotectin to exclude inflammation answer more useful questions. The microbiome also shapes mood.

Sources

1. Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. (2017). Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus. The American Journal of Gastroenterology, 112(5), 775-784. https://doi.org/10.1038/ajg.2017.46
2. Shah, A., Talley, N. J., Jones, M., Kendall, B. J., Koloski, N., Walker, M. M., Morrison, M., & Holtmann, G. J. (2020). Small intestinal bacterial overgrowth in irritable bowel syndrome: A systematic review and meta-analysis of case-control studies. The American Journal of Gastroenterology, 115(2), 190-201. https://doi.org/10.14309/ajg.0000000000000504
3. Lin, E. C., & Massey, B. T. (2016). Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth. Clinical Gastroenterology and Hepatology, 14(2), 203-8. https://doi.org/10.1016/j.cgh.2015.07.032
4. Kunkel, D., Basseri, R. J., Makhani, M. D., Chong, K., Chang, C., & Pimentel, M. (2011). Methane on breath testing is associated with constipation: A systematic review and meta-analysis. Digestive Diseases and Sciences, 56(6), 1612-8. https://doi.org/10.1007/s10620-011-1590-5
5. Takakura, W., Pimentel, M., Rao, S., Villanueva-Millan, M. J., Chang, C., Morales, W., Sanchez, M., Torosyan, J., Rashid, M., Hosseini, A., Wang, J., Leite, G., Kowalewski, E., Mathur, R., & Rezaie, A. (2022). A single fasting exhaled methane level correlates with fecal methanogen load, clinical symptoms and accurately detects intestinal methanogen overgrowth. The American Journal of Gastroenterology, 117(3), 470-477. https://doi.org/10.14309/ajg.0000000000001607
6. Pimentel, M., Chang, C., Chua, K. S., Mirocha, J., DiBaise, J., Rao, S., & Amichai, M. (2014). Antibiotic treatment of constipation-predominant irritable bowel syndrome. Digestive Diseases and Sciences, 59(6), 1278-85. https://doi.org/10.1007/s10620-014-3157-8
7. Villanueva-Millan, M. J., Leite, G., Wang, J., Morales, W., Parodi, G., Pimentel, M. L., Barlow, G. M., Mathur, R., Rezaie, A., Sanchez, M., Ayyad, S., Cohrs, D., Chang, C., Rashid, M., Hosseini, A., Fiorentino, A., Weitsman, S., Chuang, B., Chang, B., … Pimentel, M. (2022). Methanogens and hydrogen sulfide producing bacteria guide distinct gut microbe profiles and irritable bowel syndrome subtypes. The American Journal of Gastroenterology, 117(12), 2055-2066. https://doi.org/10.14309/ajg.0000000000001997
8. Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015). A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. The American Journal of Gastroenterology, 110(3), 444-54. https://doi.org/10.1038/ajg.2015.6
9. Quigley, E. M. M., Murray, J. A., & Pimentel, M. (2020). AGA Clinical Practice Update on small intestinal bacterial overgrowth: Expert review. Gastroenterology, 159(4), 1526-1532. https://doi.org/10.1053/j.gastro.2020.06.090
10. Rodriguez, J., Cordaillat-Simmons, M., Badalato, N., Berger, B., Breton, H., de Lahondès, R., Deschasaux-Tanguy, M., Desvignes, C., D’Humières, C., Kampshoff, S., Lavelle, A., Metwaly, A., Quijada, N. M., Seegers, J. F. M. L., Udocor, A., Zwart, H., Maguin, E., Doré, J., & Druart, C. (2024). Microbiome testing in Europe: Navigating analytical, ethical and regulatory challenges. Microbiome, 12(1), 258. https://doi.org/10.1186/s40168-024-01991-x

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 25 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP